Details of the Drug | DrugMAP

General Information of Drug (ID: DMICKCQ)

Drug Name

Adagloxad simolenin

Indication

Disease Entry	ICD 11	Status	REF
Triple negative breast cancer	2C60-2C65	Phase 3	[1]
Breast cancer	2C60-2C65	Phase 2/3	[2]
------------------------------------------------------------------------------------

Drug Type

Vaccine

Cross-matching ID

UNII: UCG949AA7Z
DrugBank ID: DB16082
TTD ID: DMS5N4

References

1	ClinicalTrials.gov (NCT03562637) Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)